| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/18/2011 | EP2322552A2 IL-1beta binding antibodies and fragments thereof |
| 05/18/2011 | EP2322548A1 NPC1L1 (NPC) and methods of use thereof |
| 05/18/2011 | EP2322542A1 Reproductive ablation constructs |
| 05/18/2011 | EP2322541A1 Gq protein competitive inhibitory polypeptides, preparation methods and uses thereof |
| 05/18/2011 | EP2322540A1 Lactobacillus acidophilus nucleic acids encoding fructo-oligosaccharide utilization compounds and uses thereof |
| 05/18/2011 | EP2322539A2 A method for identification, isolation and production of antigens to a specific pathogen |
| 05/18/2011 | EP2322535A2 Riboswitches, methods for their use, and compositions for use with riboswitches |
| 05/18/2011 | EP2322228A1 T cell receptor fusions and conjugates and methods of use thereof |
| 05/18/2011 | EP2322224A1 Potentiator of activity of anti-cancer agent and use thereof, and biomarker for prediction of prognosis in cancer patient and use thereof |
| 05/18/2011 | EP2322221A1 Pharmaceutical composition for treatment and prevention of cancer |
| 05/18/2011 | EP2322218A1 Methods of modulating CD200 receptors |
| 05/18/2011 | EP2322216A1 A preventive or therapeutic agent for sensitized T cell-mediated diseases comprising IL-6 antagonist as an active ingredient |
| 05/18/2011 | EP2322214A1 Immunogenic recombinant antibody |
| 05/18/2011 | EP2322212A1 Compositon of antigen and glycolipid adjuvant for sublingual administration |
| 05/18/2011 | EP2322210A1 Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide |
| 05/18/2011 | EP2322205A1 Polymer-conjugated glycosylated neublastin |
| 05/18/2011 | EP2322199A1 Growth differentiation factor receptors, and methods of using same |
| 05/18/2011 | EP2322185A2 Polynucleotide therapy |
| 05/18/2011 | EP2322165A1 Apo2 ligand/TRAIL formulations |
| 05/18/2011 | EP2322156A1 Composition for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level |
| 05/18/2011 | EP2322152A1 Method of preparing a composition comprising a GPR119 agonist |
| 05/18/2011 | EP2322151A2 Sustained release formulation comprising a GPR119 agonist and a DPP-IV inhibitor |
| 05/18/2011 | EP2322150A2 Method of identifying GLP-1 secretagogues |
| 05/18/2011 | EP2321418A1 Genetically modified seed combined with spore forming bacterium and optional insect control agents |
| 05/18/2011 | EP2321417A1 Stxbp1 as psychiatric biomarker in murine model system and their uses |
| 05/18/2011 | EP2321416A2 Plants having enhanced yield-related traits and a method for making the same |
| 05/18/2011 | EP2321415A2 The an3 protein complex and its use for plant growth promotion |
| 05/18/2011 | EP2321414A1 Enhancement of sirna silencing activity using universal bases or mismatches in the sense strand |
| 05/18/2011 | EP2321413A1 Dna mini-circles and uses thereof |
| 05/18/2011 | EP2321412A2 Stress tolerant transgenic crop plants |
| 05/18/2011 | EP2321411A1 Melk epitope peptides and vaccines containing the same |
| 05/18/2011 | EP2321354A1 Methods for identifying immunobinders of cell-surface antigens |
| 05/18/2011 | EP2321346A1 Methods and substances for stimulating muscle regeneration |
| 05/18/2011 | EP2321345A1 Multi-specific binding proteins targeting b cell disorders |
| 05/18/2011 | EP2320953A2 Long-acting dna dendrimers and methods thereof |
| 05/18/2011 | EP2320932A2 Methods of predicting cancer lethality using replikin counts |
| 05/18/2011 | EP2320931A2 Compositions comprising mg29 nucleic acids, polypeptides and associated methods of use |
| 05/18/2011 | EP2320913A1 Nucleic acid aptamers |
| 05/18/2011 | EP2164516B9 Optimized dna and protein sequence of an antibody to improve quality and yield of bacterially expressed antibody fusion proteins |
| 05/18/2011 | EP1984501B1 Mcp-i binding nucleic acids |
| 05/18/2011 | EP1966245B1 Anti-cd19 antibodies with reduced immunogenicity |
| 05/18/2011 | EP1888754B1 Promoter for epidermis-specific, pathogen-inducible transgenic expression in plants |
| 05/18/2011 | EP1799715B1 Thyrotropin receptor preparations, binding regions thereof, antibody and hormone interactions therewith, and uses thereof |
| 05/18/2011 | EP1766011B1 Methods and uses of polypeptide ligands containing linkers |
| 05/18/2011 | EP1732950B1 Antibodies to erythropoietin receptor and uses thereof |
| 05/18/2011 | EP1701611B1 Transgenic non-human mammal comprising a polynucleotide encoding human or humanized c5ar |
| 05/18/2011 | EP1565559B1 Fluorescent proteins and chromoproteins from non-aequorea hydrozoa species and methods for using same |
| 05/18/2011 | EP1478764B1 Humanized collagen antibodies and related methods |
| 05/18/2011 | EP1451325B1 Transcription factor stress-related polypeptides and methods of use in plants |
| 05/18/2011 | EP1370674B1 Enzymes having alpha amylase activity and methods of use thereof |
| 05/18/2011 | EP1366168B1 Plant-derived molecules and genetic sequences encoding same and uses therefor |
| 05/18/2011 | EP1356298B1 Diagnosis of disease |
| 05/18/2011 | EP1305422B1 2,5-dkg permeases |
| 05/18/2011 | EP1238089B1 Synthetic human genes and polypeptides and their use in the treatment of autoimmune diseases |
| 05/18/2011 | EP1131440B1 Process for oxidising terpenes |
| 05/18/2011 | EP1032595B1 Nucleic acids involved in the responder phenotype and applications thereof |
| 05/18/2011 | CN1961002B Binding molecules capable of neutralizing rabies virus and uses thereof |
| 05/18/2011 | CN1958788B Gene recombined virus of human neurenergen 3 |
| 05/18/2011 | CN1810970B CpG-containing single-stranded deoxynucleotide, its vaccine composition and their application |
| 05/18/2011 | CN1757721B Alkaline protease |
| 05/18/2011 | CN1554750B Subtilase variants and compositions |
| 05/18/2011 | CN1425068B Fungal transcriptional activator useful in methods for producing polypeptides |
| 05/18/2011 | CN1377415B 疫苗组合物 Vaccine compositions |
| 05/18/2011 | CN102066576A Method for identification of variety of hevea brasiliensis, and kit for identification of variety of hevea brasiliensis |
| 05/18/2011 | CN102066569A Plants having enhanced yield-related traits and a method for making the same |
| 05/18/2011 | CN102066568A Plants having enhanced yield-related traits and a method for making the same |
| 05/18/2011 | CN102066567A Compositions and methods for producing fermentable carbohydrates in plants |
| 05/18/2011 | CN102066566A Bollworm insect resistance management in transgenic plants |
| 05/18/2011 | CN102066565A Methods in increasing grain value by improving grain yield and quality |
| 05/18/2011 | CN102066564A Desaturase and method for the production of polyunsaturated fatty acids in transgenic organisms |
| 05/18/2011 | CN102066563A Multi-species polynucleotide control sequences |
| 05/18/2011 | CN102066562A Direct selection of structurally defined aptamers |
| 05/18/2011 | CN102066561A Method of synthesizing polynucleotide variants |
| 05/18/2011 | CN102066560A Method for production of polyester copolymer using genetically modified microorganism |
| 05/18/2011 | CN102066556A Generation of induced pluripotent stem (iPS) cells |
| 05/18/2011 | CN102066553A Coryneform bacterium transformant having improved D-xylose-utilizing function |
| 05/18/2011 | CN102066552A Cellular production of glucaric acid |
| 05/18/2011 | CN102066444A Micellic assemblies |
| 05/18/2011 | CN102066420A 1d05 pcsk9 antagonists |
| 05/18/2011 | CN102066418A Anti-HIV monoclonal antibody |
| 05/18/2011 | CN102066412A Treatment of diseases and conditions mediated by eicosanoids |
| 05/18/2011 | CN102066411A Leishmania vaccine using sand fly salivary immunogen |
| 05/18/2011 | CN102066409A Polypeptides having ferulic acid esterase activity and polynucleotides encoding same |
| 05/18/2011 | CN102066408A Toxin genes and methods for their use |
| 05/18/2011 | CN102066406A Anti-angiogenic compositions and therapeutic applications thereof |
| 05/18/2011 | CN102065996A Surface-roughened high-density functional particle, method for producing the same, and method for processing target substance using the same |
| 05/18/2011 | CN102065680A Genetically modified plant capable of biosynthesizing capsinoid |
| 05/18/2011 | CN102061526A DNA (deoxyribonucleic acid) library and preparation method thereof as well as method and device for detecting single nucleotide polymorphisms (SNPs) |
| 05/18/2011 | CN102061334A Specific DNA molecular markers for identifying genuine medicinal material of swordlike atractylodes rhizome as well as preparation method and application thereof |
| 05/18/2011 | CN102061333A Primer used for detecting c-kit gene mutation and application thereof |
| 05/18/2011 | CN102061312A Adenoviral vector of expressing ICP47 gene and construction method thereof |
| 05/18/2011 | CN102061311A Library of recombinant AAV (adeno-associated virus) carrying hGluc (human gaussia luciferase) gene-based miRNA (microRNA) sensor and application thereof |
| 05/18/2011 | CN102061310A Construction and application of human FHL1C eukaryotic expression vector |
| 05/18/2011 | CN102061309A Transgenic method for agrobacterium-mediated rice living body |
| 05/18/2011 | CN102061308A Method for screening transgenic plants by using paraquat |
| 05/18/2011 | CN102061307A Construction method of yeast two-hybrid plasmids |
| 05/18/2011 | CN102061306A Preparation method and application of immunomodulatory peptide |
| 05/18/2011 | CN102061305A Multi-ShRNA (Short Hairpin RNA) efficiently-coordinated gene silencing method and carrier |
| 05/18/2011 | CN102061304A Establishment and application of mice Leptin super-expression vector |
| 05/18/2011 | CN102061303A Fusion expression product of antimicrobial peptide genes of two marine animals and preparation method of fusion expression product |